4-(1,2-azaborinin-2(1H)-yl)-N-(2-((5-(trifluoromethyl)pyridin-2-yl)sulfonyl)ethyl)benzamide

ID: ALA5289407

Chembl Id: CHEMBL5289407

Max Phase: Preclinical

Molecular Formula: C19H17BF3N3O3S

Molecular Weight: 435.24

Names and Identifiers

Canonical SMILES:  O=C(NCCS(=O)(=O)c1ccc(C(F)(F)F)cn1)c1ccc(B2C=CC=CN2)cc1

Standard InChI:  InChI=1S/C19H17BF3N3O3S/c21-19(22,23)15-5-8-17(25-13-15)30(28,29)12-11-24-18(27)14-3-6-16(7-4-14)20-9-1-2-10-26-20/h1-10,13,26H,11-12H2,(H,24,27)

Standard InChI Key:  YPJYNRANTDIQMO-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5289407

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 435.24

Molecular Weight (Monoisotopic): 435.1036

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Subbaiah MAM, Meanwell NA..  (2021)  Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design.,  64  (19.0): [PMID:34591488] [10.1021/acs.jmedchem.1c01215]

Source

Source(1):

• Scientific Literature